Recombinant LCAT

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
259	レシチンコレステロールアシルトランスフェラーゼ欠損症	1

259. レシチンコレステロールアシルトランスフェラーゼ欠損症

臨床試験数 : 1 / 薬物数 : 1 - (DrugBank : 0) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04737720 (ClinicalTrials.gov)	January 24, 2013	3/2/2021	Intravenous ACP-501 for Familial LCAT Deficiency (rhLCAT)	Analysis of Samples Collected From a Subject Who Received ACP- 501 (Human RecombinantLecithin:Choles ...	Familial LCAT Deficiency	Drug: Recombinant LCAT	National Heart, Lung, and Blood Institute (NHLBI)	NULL	Completed	18 Years	100 Years	All	1		United States

First Previous1Next Last